7.98
Atrium Therapeutics Inc Azioni (RNA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
84.70%
3.004
|
19.64 | 0.86 | 12.47 | 3.847 |
| Operating Expenses |
30.59%
25.62
|
36.91 | 255.34 | 201.28 | 174.99 |
| Operating Income/Loss |
30.89%
-22.62
|
-17.28 | -254.48 | -188.81 | -171.14 |
| Nonoperating Income/Loss |
275.89%
2.432
|
0.647 | 17.38 | 14.36 | 13.83 |
| Net Income/Loss |
21.36%
-20.19
|
-16.63 | -237.10 | -174.44 | -157.31 |
| Basic Average Shares |
0.00%
17.11
|
17.11 | 5.429 | 137.90 | 129.62 |
| Diluted Average Shares |
0.00%
17.11
|
17.11 | 5.429 | 137.90 | 129.62 |
| Basic Earnings Per Share |
21.65%
-1.18
|
-0.97 | -1.59 | -1.27 | -1.21 |
| Diluted Earnings Per Share |
21.65%
-1.18
|
-0.97 | -1.59 | -1.27 | -1.21 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):